Coxsackievirus B4 antiserum [V-031-501-560] (ATCC® VR-1035AS/HO)

Product Format: freeze-dried 2.0 and 5.0 mL

Deposited As Coxsackievirus B4
Agent Coxsackievirus B4 antiserum [V-031-501-560]
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Source of antibody: horse
Product Format freeze-dried 2.0 and 5.0 mL
Storage Conditions 4°C
Immunogen: V-031-001-020
Source of antibody: horse
Propagated in: African green monkey kidney cells in tissue culture
Treatment: 1) Concentrated 10X by Mg-Al carbonate method; 2) 1M MgCl2 added
Name of Depositor NIH/NIAID
Source Horse immune serum prepared against Coxsackievirus B4 strain JVB.

Rosen L, Kern J. Hemagglutination and hemagglutination-inhibition with Coxsackie B viruses. Proc. Soc. Exp. Biol. Med. 107: 626-628, 1961. PubMed: 13743341

Wenner HA, Lenahan MF. Propagation of group A Coxsackie viruses in tissue cultures. II. Some interactions between virus and mammalian cells. Yale J. Biol. Med. 34: 421-438, 1961. PubMed: 14006144

Wenner. . Am. J. Epidemiol. 82: 27-39, 1965.